| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |